Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
10/2004
10/27/2004EP1470102A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
10/27/2004EP1078261B1 Method for immobilising and self-organizing biological macromolecules on carbon nanotubes and uses
10/27/2004CN1541202A Statilisation of ethylenically-unsaturated compounds with amidoximes
10/27/2004CN1172904C Process for preparing phenylacetamide
10/27/2004CN1172903C Process for preparing acetamide
10/26/2004US6809216 Waterproofing, oil repellents, antisoilants
10/26/2004US6809176 Compounds for use in treatment of cancer
10/26/2004CA2136586C Polymeric film base having a coating layer of organic solvent based polymer with a fluorinated antistatic agent
10/21/2004WO2004090147A1 Method of purifying aqueous amide compound solution and process for producing amide compound
10/21/2004WO2004089881A1 New sulfonyl derivatives of aminonaphtols
10/21/2004WO2004089877A1 New hydroxynaphthyl amides
10/21/2004WO2004089876A1 Biphenylcarboxylic amide derivatives as p38 kinease inhibitors
10/21/2004WO2004089875A1 Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors
10/21/2004WO2004089539A1 A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene
10/21/2004WO2004067482A3 Substituted anilide ligands for the thyroid receptor
10/21/2004US20040210079 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
10/21/2004US20040210078 synergistic mixtures with phenols or phenothiazines; (meth)acrylic acid, (meth)acrolein, vinyl aromatics, (meth)acrylic esters, (meth)acrylonitrile, (meth)acrylamide, olefins, or C4 to C8 conjugated dienes; nitrilotris(acetamidoxime) or nitrilotris(propionamidoxime); polymerization inhibition
10/21/2004US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004US20040209959 X-Y, in which X is a benzyl group, a saturated or unsaturated cycloalkyl group or a non-cyclic, straight or branched alkyl group, optionally in combination with another analgesic, such as an NSAID or an opioid.
10/21/2004US20040209949 Resorcinol derivatives
10/21/2004CA2520786A1 A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene
10/20/2004EP1468680A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
10/20/2004EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004EP1467964A1 Polymorphic forms of nateglinide
10/20/2004EP1467963A1 Arylation of olefins
10/20/2004EP1467728A1 Pharmaceutical compositions comprising valsartan and nep inhibitors
10/20/2004EP1443045A9 Carbanilide used as pesticide
10/20/2004EP1289936B1 Substituted stilbenes as glucose uptake enhancers
10/20/2004EP1218101A4 Stable highly active supported copper based catalysts
10/20/2004EP1144363B1 Production of formamide using sodium diformylamide
10/20/2004EP0907625A4 Fluorous reaction and separation systems
10/20/2004EP0862555B1 Substituted aryl or heteroarylamides having retinoid-like biological activity
10/20/2004CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
10/20/2004CN1171861C Halogenated amidino amino acid dervatives useful as nitric oxide synthase inhibitors
10/20/2004CN1171856C Synthetic method for amide derivatives
10/20/2004CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
10/19/2004US6806381 Process for the preparation of aniline-derived thyroid receptor ligands
10/19/2004US6806365 N-alkanoylphenylalamine derivatives
10/19/2004US6806264 Arylphenyl-substituted cyclic ketoenols
10/14/2004WO2004087655A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
10/14/2004WO2004087640A1 Process for the manufacture of n-alkoxalyl-alaninates
10/14/2004WO2004087639A1 Method for the purification of dimethylacetamide (dmac)
10/14/2004WO2004087637A1 Production of n-alkylamide compounds
10/14/2004WO2004087048A2 Benzamide modulators of metabotropic glutamate receptors
10/14/2004WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca)
10/14/2004WO2004000762A3 Propionic acid derivatives and their use as hppars activators
10/14/2004US20040204494 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/14/2004US20040202930 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
10/14/2004US20040202760 such as 2,6-nonadienamide,N-2-propenyl-,(2E,6Z); organoleptic; for addition to foods, beverages, medicine, and toothpaste
10/14/2004US20040202619 Alkyldienamides exhibiting taste and sensory effect in flavor compositions
10/14/2004DE10315214A1 Verfahren zur Reinigung von Dimethylacetamid (DMAC) A process for the purification of dimethylacetamide (DMAC)
10/14/2004CA2520689A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
10/14/2004CA2519954A1 Benzamide modulators of metabotropic glutamate receptors
10/13/2004EP1466889A1 Derivatives of venlafaxine and methods of preparing and using the same
10/13/2004EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004EP1466625A1 Preventives/remedies for urinary disturbance
10/13/2004EP1466598A2 PDE-IV inhibitors
10/13/2004EP1465863A1 Potassium channel modulators
10/13/2004EP1465860A4 An improved process for the synthesis of ( ) 2-amino-n-[2,(s,5-dimethoxyphenyl)-2-hydroxyethyl] acetamide monohydrochloride
10/13/2004EP1465860A1 An improved process for the synthesis of ( ) 2-amino-n-[2,(s,5-dimethoxyphenyl)-2-hydroxyethyl] acetamide monohydrochloride
10/13/2004EP1465835A1 Preparation of non-hazardous brominating reagents
10/13/2004EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004EP1206436B1 Retinoids for the treatment of emphysema
10/13/2004CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
10/13/2004CN1170814C Amide compounds for potentiation of cholinergic activity
10/13/2004CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/13/2004CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy
10/12/2004US6803480 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/12/2004US6803472 Method for preparing nitrogen containing compounds
10/12/2004US6803384 Diaminopropionic acid derivatives
10/12/2004US6803381 Carbamic acid derivatives
10/12/2004US6803367 Substance for inducing apoptosis
10/12/2004CA2170394C Process for conditioning substances
10/12/2004CA2100817C Heteroacetic acid derivatives
10/07/2004WO2004047738A3 Arylcyclopropylcarboxylic amides as potassium channel openers
10/07/2004WO2004043906A3 Use of trans-pellitorin in the form of an aromatic substance
10/07/2004US20040198994 wax is the reaction product of a C6-C12 linear dicarboxylic acid such as sebacic acid, a C10-C22 monocarboxylic acid such as stearic acid; andan alkylenediamine such as ethylenediamine; higher melting then other waxes
10/07/2004US20040198992 Catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition
10/07/2004US20040198977 novel sunscreen agents such as Dipotassium Salt of 2-(4-acetamidobenzylidene)malonic Acid or Dipiperidinium Salt of 2-(4-aminobenzylidene)malonic Acid; absorbing within the region of UV-B radiation; cosmetics; photostability, water solubility
10/07/2004US20040198836 reacting 1-(2,5-dimethoxyphenyl)-2-bromoethanone with hexamine, then acylating with haloacetylchloride and sodium acetate, selectively reducing with sodium borohydride and stannous chloride, and quaternization, to form midodrine and salts, used as hypertensive agents
10/07/2004US20040198797 cyclization, condensation of arylmalonic acid diamine with hydrazine forming 3-hydroxy-4-aryl-5-oxopyrazoline
10/07/2004US20040198777 obesity; antidiabetic agents; Alzheimer's disease; Huntington's disease;schizophrenia; antiproliferative agents; anticancer agents; antiepileptic agents; deafness
10/07/2004US20040198716 Cysteine protease inhimbitors
10/07/2004DE102004005583A1 Herstellungsverfahren für N-Acylaminosäure und deren Salze A method for producing N-acyl amino acid and salts thereof
10/06/2004EP1464664A1 High-melting wax useful of sintering metals
10/06/2004EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof
10/06/2004EP1463715A1 Novel glucagon antagonists
10/06/2004EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004EP1289362B1 Use of amine compounds with improved biodegradability as adjuvants for pesticides and fertilisers
10/06/2004EP1133284B1 A process for the preparation of crystalline particles
10/06/2004EP1085000B1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
10/06/2004EP1037599B1 Utilization of detergent mixtures
10/06/2004CN1535486A Novel onium salt, electrolyte for nonaqueous cell containing novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt
10/05/2004US6800788 Fluorine-containing compounds and polymers derived therefrom
10/05/2004US6800771 Stabilization of amido acids with antioxidants
10/05/2004US6800770 Anti-spasticity of an eicosanoid analog
10/05/2004US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent
10/05/2004US6800097 For dyeing keratin fibers; hair dyes
10/05/2004CA2154469C Structured copolymers and their uses as absorbents, gels and carriers of metal ions